ranolazine has been researched along with Hyperglycemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belardinelli, L; Dhalla, A; Eckel, RH; Guan, S; Henry, RH; Jochelson, P; McNabb, B; Pettus, J; Skyler, JS | 1 |
Bronsart, LL; Contag, CH; Stokes, C | 1 |
Braunwald, E; Chaitman, BR; Karwatowska-Prokopczuk, E; McCabe, CH; McGuire, DK; Morrow, DA; Murphy, SA; Scirica, BM | 1 |
Belardinelli, L; Braunwald, E; Chisholm, JW; Dhalla, AK; Goldfine, AB; Karwatowska-Prokopczuk, E; Morrow, DA | 1 |
3 trial(s) available for ranolazine and Hyperglycemia
Article | Year |
---|---|
Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Interactions; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Ranolazine; Sodium Channel Blockers; Sulfonylurea Compounds | 2016 |
Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.
Topics: Acetanilides; Acute Coronary Syndrome; Aged; Blood Glucose; Cardiovascular Agents; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Metabolic Syndrome; Middle Aged; Piperazines; Prospective Studies; Ranolazine; Recurrence | 2009 |
Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome.
Topics: Acetanilides; Acute Coronary Syndrome; Aged; Blood Glucose; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Piperazines; Placebo Effect; Ranolazine | 2010 |
1 other study(ies) available for ranolazine and Hyperglycemia
Article | Year |
---|---|
Chemiluminescence Imaging of Superoxide Anion Detects Beta-Cell Function and Mass.
Topics: Animals; Cell Respiration; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose; HeLa Cells; Humans; Hyperglycemia; Imaging, Three-Dimensional; Imidazoles; Insulin-Secreting Cells; Luminescent Measurements; Mice, Inbred NOD; Organ Size; Pyrazines; Pyridines; Ranolazine; Superoxides | 2016 |